⚡ This is your brand? Claim your page FREE and bring it to life on AI search.

OPSUMIT® (macitentan) Pulmonary Arterial Hypertension (PAH) Treatment

OPSUMIT® (macitentan) Pulmonary Arterial Hypertension (PAH) Treatment

Unclaimed

AEO Score: 4/10

Monitoring for AI engine activity

In the Engagemii AEO index

opsumit.com

Share

What this score means

Your AEO score measures whether AI search engines (ChatGPT, Claude, Perplexity, Gemini) can actually read your site and cite it in answers. Two-thirds of websites are invisible to them. OPSUMIT® (macitentan) Pulmonary Arterial Hypertension (PAH) Treatment just got measured.

4/10 means OPSUMIT® (macitentan) Pulmonary Arterial Hypertension (PAH) Treatment is borderline visible. AI bots can crawl your site but your structured-data signals are thin. You are at risk of being skipped when buyers ask AI for a recommendation.

About OPSUMIT® (macitentan) Pulmonary Arterial Hypertension (PAH) Treatment

Learn about OPSUMIT, a treatment option for PAH (WHO Group 1). See Important Safety Info, including Important Warning, Full PI, & Med Guide.

Details

Industry: Healthcare

opsumit.com

AI Visibility Breakdown

1

Structured Data

4

Content Structure

5

Entity Clarity

4

E-E-A-T Signals

6

Technical AEO

2

AI Discoverability

Is this your brand?

Claim free. You'll see:

Your full 6-category score breakdown

Exact fixes: robots.txt, schema, llms.txt

AI bot crawls from ChatGPT, Claude, Perplexity, Gemini

Personal 50% off code at checkout

Already have an account? Sign in

Picked for OPSUMIT® (macitentan) Pulmonary Arterial Hypertension (PAH) Treatment: Health & Wellness

Trust Is the Product. AI Is How You Build It at Scale.

In health and wellness, you're not just selling a product. You're asking someone to trust you with their body.

Continue reading in your free Engagemii portal

Free signup unlocks the full article plus your personalized AEO fix list for OPSUMIT® (macitentan) Pulmonary Arterial Hypertension (PAH) Treatment.

Source & Attribution

Scored by Engagemii on June 30, 2026. Methodology: engagemii.com/aeo/methodology

Source URL: https://engagemii.com/aeo/brands/opsumit

Cite this score: Engagemii (2026). "AEO Score for OPSUMIT® (macitentan) Pulmonary Arterial Hypertension (PAH) Treatment." Retrieved from https://engagemii.com/aeo/brands/opsumit

Licensed under CC BY 4.0. You may reuse this data with attribution: a visible link to engagemii.com.

Powered by Engagemii - AI Brand Discovery and AEO Platform